Chile · Delayed Price · Currency is CLP Oxiquim Statistics
Total Valuation
Oxiquim has a market cap or net worth of CLP 309.62 billion. The enterprise value is 352.35 billion.
| Market Cap | 309.62B |
| Enterprise Value | 352.35B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Apr 28, 2026 |
Share Statistics
Oxiquim has 24.89 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 24.89M |
| Shares Outstanding | 24.89M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | n/a |
| Float | 1.45M |
Valuation Ratios
The trailing PE ratio is 13.03.
| PE Ratio | 13.03 |
| Forward PE | n/a |
| PS Ratio | 1.36 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.44 |
| P/FCF Ratio | 15.13 |
| P/OCF Ratio | 8.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 17.22.
| EV / Earnings | 14.83 |
| EV / Sales | 1.55 |
| EV / EBITDA | 9.26 |
| EV / EBIT | 12.54 |
| EV / FCF | 17.22 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.53 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 1.57 |
| Debt / FCF | 2.92 |
| Interest Coverage | 11.37 |
Financial Efficiency
Return on equity (ROE) is 18.97% and return on invested capital (ROIC) is 12.82%.
| Return on Equity (ROE) | 18.97% |
| Return on Assets (ROA) | 7.32% |
| Return on Invested Capital (ROIC) | 12.82% |
| Return on Capital Employed (ROCE) | 15.36% |
| Weighted Average Cost of Capital (WACC) | 3.96% |
| Revenue Per Employee | 535.83M |
| Profits Per Employee | 55.91M |
| Employee Count | 425 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 6.67 |
Taxes
In the past 12 months, Oxiquim has paid 6.83 billion in taxes.
| Income Tax | 6.83B |
| Effective Tax Rate | 22.32% |
Stock Price Statistics
The stock price has increased by +29.93% in the last 52 weeks. The beta is -0.03, so Oxiquim's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | +29.93% |
| 50-Day Moving Average | 12,594.16 |
| 200-Day Moving Average | 12,135.15 |
| Relative Strength Index (RSI) | 32.28 |
| Average Volume (20 Days) | 416 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxiquim had revenue of CLP 227.73 billion and earned 23.76 billion in profits. Earnings per share was 954.79.
| Revenue | 227.73B |
| Gross Profit | 73.73B |
| Operating Income | 28.09B |
| Pretax Income | 30.59B |
| Net Income | 23.76B |
| EBITDA | 37.54B |
| EBIT | 28.09B |
| Earnings Per Share (EPS) | 954.79 |
Balance Sheet
The company has 17.04 billion in cash and 59.77 billion in debt, with a net cash position of -42.73 billion or -1,717.03 per share.
| Cash & Cash Equivalents | 17.04B |
| Total Debt | 59.77B |
| Net Cash | -42.73B |
| Net Cash Per Share | -1,717.03 |
| Equity (Book Value) | 127.04B |
| Book Value Per Share | 5,104.81 |
| Working Capital | 25.85B |
Cash Flow
In the last 12 months, operating cash flow was 35.47 billion and capital expenditures -15.01 billion, giving a free cash flow of 20.46 billion.
| Operating Cash Flow | 35.47B |
| Capital Expenditures | -15.01B |
| Depreciation & Amortization | 9.79B |
| Net Borrowing | -6.31B |
| Free Cash Flow | 20.46B |
| FCF Per Share | 822.14 |
Margins
Gross margin is 32.37%, with operating and profit margins of 12.33% and 10.43%.
| Gross Margin | 32.37% |
| Operating Margin | 12.33% |
| Pretax Margin | 13.43% |
| Profit Margin | 10.43% |
| EBITDA Margin | 16.48% |
| EBIT Margin | 12.33% |
| FCF Margin | 8.98% |
Dividends & Yields
This stock pays an annual dividend of 1,085.00, which amounts to a dividend yield of 8.72%.
| Dividend Per Share | 1,085.00 |
| Dividend Yield | 8.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 84.78% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 8.72% |
| Earnings Yield | 7.67% |
| FCF Yield | 6.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oxiquim has an Altman Z-Score of 3.66 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 5 |